These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 19967796)
1. Escaping the pincer. Nat Rev Drug Discov; 2009 Dec; 8(12):915. PubMed ID: 19967796 [No Abstract] [Full Text] [Related]
2. Pharmaceutical R&D: the road to positive returns. David E; Tramontin T; Zemmel R Nat Rev Drug Discov; 2009 Aug; 8(8):609-10. PubMed ID: 19644471 [No Abstract] [Full Text] [Related]
3. How should we support pharmaceutical innovation? Grootendorst P Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991 [TBL] [Abstract][Full Text] [Related]
4. Looking outward: content as a service starts to make sense. Sherlock A Drug Discov Today; 2013 Jan; 18(1-2):1-3. PubMed ID: 23041498 [No Abstract] [Full Text] [Related]
6. Drug discovery: are productivity metrics inhibiting motivation and creativity? Ullman F; Boutellier R Drug Discov Today; 2008 Nov; 13(21-22):997-1001. PubMed ID: 18652910 [TBL] [Abstract][Full Text] [Related]
7. China spurs pharma innovation. Hughes B Nat Rev Drug Discov; 2010 Aug; 9(8):581-2. PubMed ID: 20671751 [No Abstract] [Full Text] [Related]
8. Daniel Vasella. Hughes B Nat Rev Drug Discov; 2010 Feb; 9(2):98. PubMed ID: 20118958 [No Abstract] [Full Text] [Related]
9. Reviving an R&D pipeline: a step change in the Phase II success rate. Wu SS; Fernando K; Allerton C; Jansen KU; Vincent MS; Dolsten M Drug Discov Today; 2021 Feb; 26(2):308-314. PubMed ID: 33129994 [TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical futures: made in China? Cyranoski D Nature; 2008 Oct; 455(7217):1168-70. PubMed ID: 18971994 [No Abstract] [Full Text] [Related]
11. An audience with...Marc Cluzel. Cluzel M Nat Rev Drug Discov; 2010 Jan; 9(1):14. PubMed ID: 20043024 [TBL] [Abstract][Full Text] [Related]
12. What should be done to improve the productivity of neurological research? Moses H; Martin JB Ann Neurol; 2006 Dec; 60(6):647-51. PubMed ID: 17192925 [No Abstract] [Full Text] [Related]
13. Back to the future. Offit P Expert Rev Vaccines; 2004 Apr; 3(2):107-8. PubMed ID: 15056035 [No Abstract] [Full Text] [Related]
16. The case for entrepreneurship in R&D in the pharmaceutical industry. Douglas FL; Narayanan VK; Mitchell L; Litan RE Nat Rev Drug Discov; 2010 Sep; 9(9):683-9. PubMed ID: 20725093 [TBL] [Abstract][Full Text] [Related]
17. Reproducibility: Team up with industry. Edwards A Nature; 2016 Mar; 531(7594):299-301. PubMed ID: 26983524 [No Abstract] [Full Text] [Related]
18. Merck's recall of rofecoxib--a strategic perspective. Oberholzer-Gee F; Inamdar SN N Engl J Med; 2004 Nov; 351(21):2147-9. PubMed ID: 15548771 [No Abstract] [Full Text] [Related]
19. Models for open innovation in the pharmaceutical industry. Schuhmacher A; Germann PG; Trill H; Gassmann O Drug Discov Today; 2013 Dec; 18(23-24):1133-7. PubMed ID: 23892183 [TBL] [Abstract][Full Text] [Related]